← SynDRA
SB-649868
SynDRA canonical compound SYN0024832 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HCRTR1 | HCRTR2 |
|---|
| Mechanism of action | orexin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- HCRTR1 ANTAGONIST
- Orexin receptor 1 antagonist
- HCRTR2 ANTAGONIST
- Orexin receptor 2 antagonist
- orexin receptor antagonist
Cross-references
Synonyms
- GSK649868
- SB 649868
- UNII-1L1V1K2M4V
- 1L1V1K2M4V
- SB649868
- GTPL4461
- N-[[(2S)-1-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]piperidin-2-yl]methyl]-1-benzofuran-4-carboxamide
- SCHEMBL8045969
- CHEMBL1272307
- DTXSID90191491
- EX-A2570
- BDBM50417257
- AKOS027323765
- CS-7584
- SB19110
- HY-10806
- SB-649,868
- N-((1-((5-(4-Fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide
- 4-Benzofurancarboxamide, N-(((2S)-1-((5-(4-fluorophenyl)-2-m
- RefChem:926512
- DTXCID00113982
- C26H24FN3O3S
- MFCD18251524
- orb1301739
- SCHEMBL29424764
- GLXC-03492
- AC-36150
- BS-50120
- DA-77718
- SB649868; GSK649868
- T5498
- D82888
- F862516
Look up SB-649868 in the interactive SynDRA portal →